(Q33415631)

English

FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer

scientific article

Statements

FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer (English)
Laleh Amiri-Kordestani
Sarah Pope Miksinski
Rajeshwari Sridhara

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit